Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
29 results
D2.422 - Supporting second victims: linkages between patient safety and well-being of healthcare workers in allergy departments
D2.423 - Occupational sensitisation to Chrysonilia sitophila in an asthmatic patient with nasal polyposis
D2.424 - Allergenic and inflammatory response of combined exposure of shrimp tropomyosin and microbial components in vitro
D2.425 - Prevalence of Latex Sensitization Among Nursing Staff in Intensive Care Units at the Hospital Universitario Austral: Comparative Analysis and Associated Factors
D2.426 - Occupational Asthma Due to Tenebrio Molitor in the Owner of a Mealworm Farm: A Case Report
D2.428 - Asthma severity and work exposure in 66 patient reffered to occupational and allergy unit
D2.429 - Biologic Therapy in Occupational Asthma: A Multicenter Retrospective Study on Treatment Outcomes and Occupational Impact
- D3.24 - From angioedema to Kimura disease: Diagnostic challenge
- D3.27 - Chlorhexidine as a Hidden Everyday Allergen
D3.17 - Systemic Histaminergic Findings in Children with Chronic Urticaria
D3.18 - Allergy to Isobornyl Acrylate (IBOA) present in Sensors and Insulin Infusion Systems in Pediatric Population
D3.19 - Evaluation of allergens in Atopic Dermatitis in children between 6 months and 18years
D3.20 - Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media
D3.22 - Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool
D3.23 - Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre
D3.26 - Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis
D3.28 - Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria
D3.29 - Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients
D3.30 - Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study
D3.31 - Successful Management of Primary Cold Urticaria in Medical Practitioners: A Small Case Series
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download